萨瑞普塔治疗 SRPT
$17.82 +$0.25 (+1.42%)
休市 · Nov 7, 9:10 am ET · 最新盘后价 $17.82 0.00%
开盘$18.77
昨收$17.57
当日区间$17.52 – $18.77
成交量2.60M
市值$1.91B
市盈率（TTM）–
股息率–
财报
财报日平均波动±8.7%近16次财报
收涨次数6 / 1638% 的概率
最佳反应+19.2%
最差反应-33.7%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q2 | 5 Aug 2026 | After Market | ±8.0% | +5.34% | 符合区间 |
| 2026/Q1 | 6 May 2026 | After Market | ±9.4% | -9.68% | 超出定价预期 |
| 2025/Q4 | 25 Feb 2026 | After Market | ±9.8% | -8.01% | 符合区间 |
| 2025/Q3 | 3 Nov 2025 | After Market | ±19.5% | -33.74% | 超出定价预期 |
| 2025/Q2 | 6 Aug 2025 | After Market | ±12.4% | +10.46% | 符合区间 |
| 2025/Q1 | 6 May 2025 | After Market | ±16.9% | -21.45% | 超出定价预期 |
| 2024/Q4 | 26 Feb 2025 | After Market | ±7.9% | -3.56% | 符合区间 |
| 2024/Q3 | 6 Nov 2024 | After Market | ±9.4% | -5.90% | 符合区间 |
| 2024/Q2 | 7 Aug 2024 | After Market | ±10.6% | -2.61% | 符合区间 |
| 2024/Q1 | 1 May 2024 | After Market | ±7.2% | -0.21% | 符合区间 |
| 2023/Q4 | 28 Feb 2024 | After Market | ±7.9% | -6.98% | 符合区间 |
| 2023/Q3 | 1 Nov 2023 | After Market | ±8.8% | +1.62% | 符合区间 |
| 2023/Q2 | 2 Aug 2023 | After Market | ±6.5% | +2.05% | 符合区间 |
| 2023/Q1 | 2 May 2023 | After Market | ±6.8% | +1.41% | 符合区间 |
| 2022/Q4 | 28 Feb 2023 | After Market | ±7.2% | +19.24% | 超出定价预期 |
| 2022/Q3 | 2 Nov 2022 | After Market | ±4.8% | -7.41% | 超出定价预期 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
营收构成
2026/Q2 季度
按业务线
基本面
最新报告季度：Q2, ended Jun 2026
营收$401.25M-34.3% YoY
营业利润$52.29M-54.8% YoY
净利润-$4.89M-102.5% YoY
摊薄每股收益-$0.05-102.6% YoY
自由现金流$196.52M-14.5% YoY
经营现金流$197.07M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
毛利率59.1%
营业利润率-3.2%
净利率-6.9%
净资产收益率-9.5%
资产收益率-4.0%
投入资本回报率-4.3%
流动比率4.42
负债/资产比率52.1%
现金及投资$788.49M
总负债$1.05B
净现金（净负债）-$257.36M
自由现金流/营收3.8%
暂无评论——快来第一个聊聊 SRPT。
登录后参与讨论。